XSHE
002172
Market cap336mUSD
Jul 10, Last price
2.97CNY
1D
3.48%
1Q
-24.23%
Jan 2017
-70.97%
IPO
-75.76%
Name
Jiangsu Aoyang Health Industry Co Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Jiangsu Aoyang Health Industry Co.ltd. is a multifaceted enterprise primarily engaged in two key sectors: chemical fiber manufacturing and healthcare services. Globally, the company manufactures and distributes a range of chemical fibers, including advanced functional fibers and traditional viscose varieties. Complementing its industrial activities, Aoyang Health maintains a significant presence in the health sector. This includes the operation of hospitals, rehabilitation facilities, and retail pharmaceutical outlets. Furthermore, its healthcare portfolio extends to offering comprehensive health management solutions, managing pharmaceutical logistics, and distributing medical products. Established in 2001 and headquartered in Zhangjiagang, China, the entity underwent a name change in September 2018, transitioning from its previous designation, Jiangsu Aoyang Technology Corporation Limited, to its current identity.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2023‑00 | 2022‑12 | 2022‑00 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||||
Revenues | ||||||||||||
Cost of revenue | ||||||||||||
Unusual Expense (Income) | ||||||||||||
NOPBT | ||||||||||||
NOPBT Margin | ||||||||||||
Operating Taxes | ||||||||||||
Tax Rate | ||||||||||||
NOPAT | ||||||||||||
Net income | ||||||||||||
Dividends | ||||||||||||
Dividend yield | ||||||||||||
Proceeds from repurchase of equity | ||||||||||||
BB yield | ||||||||||||
| Debt | ||||||||||||
Debt current | ||||||||||||
Long-term debt | ||||||||||||
Deferred revenue | ||||||||||||
Other long-term liabilities | ||||||||||||
Net debt | ||||||||||||
| Cash flow | ||||||||||||
Cash from operating activities | ||||||||||||
CAPEX | ||||||||||||
Cash from investing activities | ||||||||||||
Cash from financing activities | ||||||||||||
FCF | ||||||||||||
| Balance | ||||||||||||
Cash | ||||||||||||
Long term investments | ||||||||||||
Excess cash | ||||||||||||
Stockholders' equity | ||||||||||||
Invested Capital | ||||||||||||
ROIC | ||||||||||||
ROCE | ||||||||||||
| EV | ||||||||||||
Common stock shares outstanding | ||||||||||||
Price | ||||||||||||
Market cap | ||||||||||||
EV | ||||||||||||
EBITDA | ||||||||||||
EV/EBITDA | ||||||||||||
Interest | ||||||||||||
Interest/NOPBT | ||||||||||||